Novartis Ups Mid-Term Targets
Wall Street Journal
Novartis said it aims for annual sales growth of 5% through 2027 after what it called a progress in delivering its pure-play strategy.
https://www.wsj.com/articles/novartis-raises-mid-term-sales-growth-targets-7c1e78d7